Clinical Trial Update: Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae [Phase 3]

View source ↗

Summary

Phase 3 trial of intermittent preventive treatment with sulfadoxine-pyrimethamine in Gambian multigravidae for malaria prevention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 3 | Status: COMPLETED